Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-500
Closed -$8K 143
2023
Q4
$8K Sell
500
-500
-50% -$8.28K 0.01% 137
2023
Q3
$23K Hold
1,000
0.02% 133
2023
Q2
$32K Sell
1,000
-19
-2% -$608 0.02% 134
2023
Q1
$30K Hold
1,019
0.02% 130
2022
Q4
$48K Hold
1,019
0.04% 133
2022
Q3
$41K Hold
1,019
0.04% 117
2022
Q2
$39K Hold
1,019
0.03% 114
2022
Q1
$49K Hold
1,019
0.03% 122
2021
Q4
$64K Buy
+1,019
New +$80.3K 0.04% 119

Other funds holding AGEN

O'Rourke & Company's AGEN Position: Q1 2024 in Review

O'Rourke & Company sold out of Agenus (AGEN) in Q1 2024, closing a stake of 500 shares — an estimated $8K sold.

O'Rourke & Company first reported a position in AGEN in Q4 2021 and held it in 9 quarters. The position peaked at $64K in Q4 2021. 124 funds tracked by Wall St. Rank hold AGEN as of Q1 2024.

  • O'Rourke & Company reported no remaining Agenus position as of Q1 2024 after selling out during the quarter.
  • O'Rourke & Company sold 500 Agenus shares in Q1 2024, an estimated $8K.
  • O'Rourke & Company first reported a position in Agenus in Q4 2021 and held it in 9 quarters.
  • O'Rourke & Company's Agenus position peaked at $64K in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Agenus as of Q1 2024.

Based on O'Rourke & Company's 13F filing for Q1 2024, filed 18 Apr 2024.